Methodology: A crosssectional descriptive study was conducted on 112 patients diagnosed with paranoid schizophrenia, treated at the National Institute of Mental Health from August 2021 to March 2022, evaluating based on medical records and a psychological test named the Pittsburgh Sleep Quality Index (PSQI).